Image de couverture de livre

HABIT Efficacy Trial Intervention Improves Elements of General and Disease‐Specific Quality of Life in Youth With Sickle Cell Disease

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Arlene Smaldone, Deepa Manwani, Banu Aygun, Abena Appiah‐Kubi, Kim Smith‐Whitley, Nancy S. Green
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pediatric Blood & Cancer
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy‐based refill records
par: Arlene Smaldone, et autres
Publié: (2024)

Comment on: “Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell disease”: Participant evaluation
par: Mary F. Martin, et autres
Publié: (2024)

Characterizing Engagement With a Mobile Health Application Designed for Adolescents and Young Adults With Sickle Cell Disease: Findings From the COMETS Study
par: Caren Steinway, et autres
Publié: (2026)

The Role of Associated Treatment Factors and Mental Health on Transition From Pediatric to Adult Care for Adolescent/Young Adults With Sickle Cell Disease
par: Caryn R. R. Rodgers, et autres
Publié: (2025)

Sickle Cell Disease‐Related Stigma: Quantitative Assessment From India
par: Bontha V. Babu, et autres
Publié: (2025)

Unheard and Under‐Supported: Health‐Related Quality of Life in Children, Adolescents, and Young Adults With Sickle Cell Disease
par: Desiré Fantasia, et autres
Publié: (2026)

Prevalence and Impact of Autism Spectrum Disorder and Selected Neurodevelopmental Diagnoses in Hospitalized Youth With Sickle Cell Disease
par: Megan M. Griffith, et autres
Publié: (2025)

Caregiver Well‐Being and Pediatric Healthcare Utilization in Youth With Sickle Cell Disease: The Role of Caregiver and Child Factors
par: Theresa L. Kapke, et autres
Publié: (2025)

Sensitivity and Specificity of a Signaling Question for Surveillance of Cognitive Functioning in Pediatric Sickle Cell Disease
par: Steven J. Hardy, et autres
Publié: (2025)

Sickle Cell Disease and Hemoglobin S Prevalence in Botswana
par: Setho Ruth Taboka Kgakatsi, et autres
Publié: (2025)

User Perceptions of a Multilevel mHealth Intervention to Boost Adherence to Hydroxyurea in Sickle Cell Disease
par: Christina M. Abrams, et autres
Publié: (2025)

Pregnancy‐ and Disease‐Related Morbidity Among Medicaid Enrollees With Sickle Cell Disease
par: Mariam Kayle, et autres
Publié: (2025)

Association of Food Insecurity With Disease‐Related Complications and Healthcare Utilization for Patients With Sickle Cell Disease
par: Sharjeel Syed, et autres
Publié: (2025)

Reproductive Health and Pregnancy Outcomes Among Women With Sickle Cell Disease in Tribal Communities of India: A Community‐Based Retrospective Comparative Study
par: Yogita Sharma, et autres
Publié: (2026)

Engaging Parents of Children With Sickle Cell Disease in Shared Decision‐Making for Hydroxyurea: The ENGAGE‐HU Study
par: Aimee K. Hildenbrand, et autres
Publié: (2025)

Prevalence and Significance of Pancreatic Iron in Transfusion‐Dependent Sickle Cell Disease
par: Akhila Vadivelan, et autres
Publié: (2025)

Medication Utilization Among Children With Sickle Cell Disease in the United States
par: Abiodun John Ologunowa, et autres
Publié: (2025)

The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease?
par: Charles T. Quinn, et autres
Publié: (2024)

Hydroxyurea Therapy and Sleep‐Disordered Breathing in Children With Sickle Cell Disease
par: Zachary Abramson, et autres
Publié: (2025)

Statewide Academic Performance of High School Students With Sickle Cell Disease
par: Andrew M. Heitzer, et autres
Publié: (2025)

Screening and Impact of Neuropathic Pain in Young Individuals With Sickle Cell Disease
par: Amira Adly, et autres
Publié: (2024)

Hospitalization Through Families’ Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada
par: Hailey M. Zwicker, et autres
Publié: (2026)

Sickle Cell Disease Is an Inherent Risk for Asthma in a Sibling Comparison Study
par: Suhei C. Zuleta De Bernardis, et autres
Publié: (2026)

Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease
par: Rhayane Vitória Lopes, et autres
Publié: (2025)

How We Approach Contraception for Adolescents and Young Adults With Sickle Cell Disease
par: Maayan Leroy‐Melamed, et autres
Publié: (2025)

Impact of Neighborhood Disadvantage on Preventive and Acute Care Utilization in Sickle Cell Disease
par: Ashley Catanzarite, et autres
Publié: (2024)

Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic Issues
par: Caroline Vinit, et autres
Publié: (2025)

Prevalence of Duffy Null and Its Impact on Hydroxyurea Dosing in Children With Sickle Cell Disease
par: Jill S. Menell, et autres
Publié: (2025)

Clinical Practice Patterns for Discussing Hydroxyurea Initiation With Families of Children With Sickle Cell Disease
par: Aimee K. Hildenbrand, et autres
Publié: (2026)

Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype
par: Nate Goldfarb, et autres
Publié: (2025)

Optimizing Transcranial Doppler Screening for Stroke Prevention in Young African Children With Sickle Cell Disease
par: Derby Tembo, et autres
Publié: (2025)

Does Hydroxyurea Reduce Hospital Admissions in Patients With Both Sickle Cell Disease and Dengue Fever?
par: Narcisse Elenga, et autres
Publié: (2026)

Osteopathic Manipulative Treatment: A Safe and Feasible Adjunct in Sickle Cell Disease Pain Management
par: Amber Brown, et autres
Publié: (2024)

Improving Completion Rates of Transcranial Doppler Ultrasounds in Children With Sickle Cell Disease Using Quality Improvement Efforts: In‐Clinic Versus Population‐Based Assessments
par: Madhav Vissa, et autres
Publié: (2025)

Clinical Features and Outcomes of Pneumococcal Bacteremia in Children With Sickle Cell Disease in the Pneumococcal Conjugate Vaccine Era
par: Marianne E. Yee, et autres
Publié: (2025)

Socioeconomic Status and Stroke Risk in Pediatric Sickle Cell Disease: A DISPLACE Study Secondary Analysis
par: Jeffrey G. Edwards, et autres
Publié: (2025)

Pulmonary Dysfunction Is Associated With Sleep Study Abnormalities in Children With Sickle Cell Disease: A Multicenter Study
par: Ammar Saadoon Alishlash, et autres
Publié: (2026)

Delayed Presentation of Transfusion‐Associated Circulatory Overload Associated With Splenic Sequestration Management in Sickle Cell Disease
par: Laura S. Duarte, et autres
Publié: (2024)

Correction to “Engaging Parents of Children With Sickle Cell Disease in Shared Decision‐Making for Hydroxyurea: The ENGAGE‐HU Study”
Publié: (2026)

Treatment Experience Using a Micro‐Induction Buprenorphine Protocol for Chronic Pain in Pediatric Sickle Cell Disease
par: Ashwin Patel, et autres
Publié: (2025)